PT - JOURNAL ARTICLE AU - Liu, Dongjing AU - Meyer, Dara AU - Fennessy, Brian AU - Feng, Claudia AU - Cheng, Esther AU - Johnson, Jessica S. AU - Park, You Jeong AU - Rieder, Marysia-Kolbe AU - Ascolillo, Steven AU - de Pins, Agathe AU - Dobbyn, Amanda AU - Lebovitch, Dannielle AU - Moya, Emily AU - Nguyen, Tan-Hoang AU - Wilkins, Lillian AU - Hassan, Arsalan AU - , AU - , AU - Burdick, Katherine E. AU - Buxbaum, Joseph D. AU - Domenici, Enrico AU - Frangou, Sophia AU - Hartmann, Annette M. AU - Malhotra, Dheeraj AU - Pato, Carlos N. AU - Pato, Michele T. AU - Ressler, Kerry AU - Roussos, Panos AU - Rujescu, Dan AU - Arango, Celso AU - Bertolino, Alessandro AU - Blasi, Giuseppe AU - Bocchio-Chiavetto, Luisella AU - Campion, Dominique AU - Carr, Vaughan AU - Fullerton, Janice M. AU - Gennarelli, Massimo AU - González-Peñas, Javier AU - Levinson, Douglas F. AU - Mowry, Bryan AU - Nimgaokar, Vishwajit L. AU - Pergola, Giulio AU - Rampino, Antonio AU - Rivera-Sanchez, Margarita AU - Schwab, Sibylle G. AU - Wildenauer, Dieter B. AU - Daly, Mark AU - Neale, Benjamin AU - Singh, Tarjinder AU - O’Donovan, Michael C. AU - Owen, Michael J. AU - Walters, James T. AU - Ayub, Muhammad AU - Malhotra, Anil K. AU - Lencz, Todd AU - Sullivan, Patrick F. AU - Sklar, Pamela AU - Stahl, Eli A. AU - Huckins, Laura M. AU - Charney, Alexander W. TI - Rare schizophrenia risk variant burden is conserved in diverse human populations AID - 10.1101/2022.01.03.22268662 DP - 2022 Jan 01 TA - medRxiv PG - 2022.01.03.22268662 4099 - http://medrxiv.org/content/early/2022/01/03/2022.01.03.22268662.short 4100 - http://medrxiv.org/content/early/2022/01/03/2022.01.03.22268662.full AB - Schizophrenia is a chronic mental illness that is amongst the most debilitating conditions encountered in medical practice. A recent landmark schizophrenia study of the protein-coding regions of the genome identified a causal role for ten genes and a concentration of rare variant signals in evolutionarily constrained genes1. This study -- and most other large-scale human genetic studies -- was mainly composed of individuals of European ancestry, and the generalizability of the findings in non-European populations is unclear. To address this gap in knowledge, we designed a custom sequencing panel based on current knowledge of the genetic architecture of schizophrenia and applied it to a new cohort of 22,135 individuals of diverse ancestries. Replicating earlier work, cases carried a significantly higher burden of rare protein-truncating variants among constrained genes (OR=1.48, p-value = 5.4 × 10−6). In meta-analyses with existing schizophrenia datasets totaling up to 35,828 cases and 107,877 controls, this excess burden was largely consistent across five continental populations. Two genes (SRRM2 and AKAP11) were newly implicated as schizophrenia risk genes, and one gene (PCLO) was identified as a shared risk gene for schizophrenia and autism. Overall, our results lend robust support to the rare allelic spectrum of the genetic architecture of schizophrenia being conserved across diverse human populations.Competing Interest StatementM.C.O, M.J.O, and J.T.W. are supported by a collaborative research grant from Takeda Pharmaceuticals. A.K.M is a sonsultant at Genomind Inc, InformedDNA. D.M. is a full-time employee of F.Hoffmann-La Roche.C.A. has been a consultant to or has received honoraria or grants from Acadia, Angelini, Biogen, Boehringer, Gedeon Richter, Janssen Cilag, Lundbeck, Medscape, Minerva, Otsuka, Pfizer, Roche, Sage, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion and Takeda. E.A.S is an employee of Regeneron. The remaining authors declare no competing interests.Funding StatementA.W.C. is support by the NIMH (R01MH109536). L.M.H. is supported by the NIMH (R01MH118278; R01MH124839; U01MH109536). M.C.O., M.J.O., and J.T.R.W. are supported by Medical Research Council Centre Grant No. MR/L010305/1 and Programme MR/P005748/1. For sample acquisition, curation and preparation, we are grateful to Leyden Delta, Magna Laboratories, and their staff (Marinka Helthuis, John Jansen and Adrian King). We also thank Lucinda Hopkins and the core laboratory team at Cardiff University.K.E.B. is supported by R01MH100125 and 1I01CX000995. J.D.B. is supported by P50MH066392. J.M.F. is supported by the Janette Mary ONeil Research Fellowship, and Australian National Medical and Health Research Council (NHMRC) Project Grant 1063960. P.R.S. is supported by the Australian National Medical and Health Research Council (NHMRC) Program Grant 1037196 and Investigator Grant 1176716. D.B.W. and S.G.S. are supported by NHMRC grant 513861. M.R. has been funded by Instituto de Salud Carlos III projects "PI18/00238" and "PI18/00467" (Co-funded by European Regional Development Fund / European Social Fund "A way to make Europe"/"Investing in your future"). C.A. has received support from the Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (PI19/024), co-financed by ERDF Funds from the European Commission, "A way of making Europe", CIBERSAM, Madrid Regional Government (B2017/BMD-3740 AGES-CM-2), and European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking (grant agreement No 115916, Project PRISM, and grant agreement No 777394, Project AIMS-2-TRIALS), Fundacion Familia Alonso, and Fundacion Alicia Koplowitz. M.G. and the work at IRCCS Centro S. Giovanni di Dio, Fatebenefratelli is supported by the Italian Ministry of Health (Ricerca Corrente).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The current study was approved by the Icahn School of Medicine at Mount Sinai Institutional Review Board. Original sample collections was approved by the IRB at each collecting site.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced will be deposited to dbGAP.